About SensOmics
SensOmics is a Healthcare company based in Toronto (Canada) founded in 2007. It operates as a precision medicine for childrens health is provided through genomic integration. SensOmics offers products and services including SensWatch BP, SensWatch R, and Data Platform. Its focus areas include Life Sciences, Clinical Genomics, Sequencing Based and Diversified. Its competitors include MedGenome, Foundation Medicine, Personalis, Veritas Genetics and Burning Rock and 4 more; 9 of its 9 listed competitors have raised funding.
Company details
SensOmics was founded in 2007 in Toronto, Canada, within the precision medicine sector. Childrens health is addressed through the integration of genomics, clinical informatics, and machine learning to analyze the human genome. A primary focus is placed on Autism, with operations centered on developing targeted health solutions. Services encompass data-driven insights for pediatric care in North America.
- Headquarters Toronto, Canada
- SectorsHealthcare
- Website sensomics.com
- InvestorsAsset Management Ventures
& 1 more
Products & Services of SensOmics
SensOmics offers a comprehensive portfolio of products and services, including SensWatch BP, SensWatch R, and Data Platform.
Monitors blood pressure continuously for accurate health tracking.
Tracks physiological parameters in real-time for advanced monitoring.
Analyzes health data using AI for insights and alerts.
Funding Insights of SensOmics
- Total Rounds 1
- Investors Count 2
All 1 funding rounds of SensOmics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2017 | – | Seed | – | – |
2 investors in total: 2 institutional.
Investors in SensOmics
SensOmics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Asset Management Ventures and iSeed Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage US companies are invested in by Asset Management Ventures. | – | assetman.com | Palo Alto, United States | |
Venture capital firm investing in AI and digital health startups based in San Francisco. | – | iseedvc.com | - |
Investor details for SensOmics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of SensOmics
2 dated milestones of SensOmics across 10 years, from founding to its latest funding, stage changes and deals.
- Founded SensOmics is founded.
- Funding First funding round.
Competitors of SensOmics
SensOmics has 9 listed competitors in our database, 9 of them funded. They include MedGenome, Foundation Medicine, Personalis, Veritas Genetics and Burning Rock, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| medgenome.com | 2013 | Bengaluru, India | $264.5M | 922 | DNA sequencing, bioinformatics, and multiomics services are provided. | |
| foundationmedicine.com | 2010 | Cambridge, United States | $96.5M | 1,707 | Genomics-based diagnostic tests for cancer are provided. | |
| personalis.com | 2011 | Menlo Park, United States | $87.3M | 310 | Genomic sequencing and diagnosis software is provided for healthcare. | |
| veritasgenetics.com | 2014 | Danvers, United States | $53.38M | 14 | Genetic testing products for health risks and traits are offered. | |
| brbiotech.com | 2014 | Guangzhou, China | $203.32M | – | Personalized cancer diagnostics are developed using genomic big data analysis. | |
| lanternpharma.com | 2013 | Dallas, United States | $7.12M | 23 | Drug and companion diagnostics for multi-drug resistant cancers are developed. | |
| novogene.com | 2011 | Beijing, China | $75M | 141 | Genomic services and solutions with NGS expertise are provided. | |
| newhorizonbio.com | 2013 | Beijing, China | $151.83M | – | Provider of early cancer screening and testing services | |
| personalgenome.com | 2010 | Baltimore, United States | $327.45M | 109 | Provider of advanced technology solutions for cancer genome analysis |
Detailed competitors of SensOmics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of SensOmics
The website of SensOmics (sensomics.com) receives about 1K visits a month.
- Monthly visits1K
▼ 21.3% vs previous month
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as SensOmics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SensOmics
SensOmics was founded in 2007 and raised its 1st funding round 10 years after it was founded.
SensOmics is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
SensOmics was founded in 2007 in Toronto, Canada, within the precision medicine sector. Childrens health is addressed through the integration of genomics, clinical informatics, and machine learning to analyze the human genome. A primary focus is placed on Autism, with operations centered on developing targeted health solutions. Services encompass data-driven insights for pediatric care in North America.
SensOmics's top competitors include Foundation Medicine, MedGenome and Personalis.
SensOmics offers SensWatch BP, SensWatch R, and Data Platform.
SensOmics has 2 investors. Key investors include Asset Management Ventures, and iSeed Ventures.